Literature DB >> 16215708

[Gleason grading: diagnostic criteria and clinical implications].

H Bonkhoff1.   

Abstract

Prostate cancer offers a wide spectrum ranging from clinically insignificant to aggressive and fatal disease. The Gleason grade is a powerful prognostic indicator and does influence treatment decision. Educational programs and websites are currently available to improve reproducibility and reliability of Gleason grading. A major problem in reporting of Gleason grading in needle biopsy is undergrading. The Gleason grade 3 is the lowest grade which can be assigned reliably in needle biopsies. The major prognostic shift is between Gleason grades 3 und 4 which is characterized by fusion of the glandular formations. Reporting the proportion of Gleason grades 4 and 5 in needle biopsies may be critical in terms of treatment decisions. The present review deals with diagnostic criteria of the Gleason grades and its clinical implications.

Entities:  

Mesh:

Year:  2005        PMID: 16215708     DOI: 10.1007/s00292-005-0793-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  8 in total

1.  The role of intraductal carcinoma in the natural history of prostatic adenocarcinoma.

Authors:  J E McNeal
Journal:  Eur Urol       Date:  2001-04       Impact factor: 20.096

2.  Current practice of Gleason grading among genitourinary pathologists.

Authors:  Lars Egevad; William C Allsbrook; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2005-01       Impact factor: 3.466

Review 3.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

4.  Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.

Authors:  H J Dawkins; L N Sellner; G R Turbett; C A Thompson; S L Redmond; J E McNeal; R J Cohen
Journal:  Prostate       Date:  2000-09-01       Impact factor: 4.104

Review 5.  Pathological and molecular aspects of prostate cancer.

Authors:  Angelo M DeMarzo; William G Nelson; William B Isaacs; Jonathan I Epstein
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

Review 6.  Gleason grading and prognostic factors in carcinoma of the prostate.

Authors:  Peter A Humphrey
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

Review 7.  Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.

Authors:  Jonathan I Epstein
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

Review 8.  Radical prostatectomy for carcinoma of the prostate.

Authors:  Makoto Ohori; Michael Kattan; Peter T Scardino; Thomas M Wheeler
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

  8 in total
  2 in total

1.  Improving the reproducibility of the Gleason scores in small foci of prostate cancer--suggestion of diagnostic criteria for glandular fusion.

Authors:  B Helpap; G Kristiansen; M Beer; J Köllermann; U Oehler; A Pogrebniak; Ch Fellbaum
Journal:  Pathol Oncol Res       Date:  2011-12-17       Impact factor: 3.201

2.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.